During the past decade, Cancer Center of Kansas - Main Office conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 33 clinical trials were completed, i.e. on average, 1650% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Center of Kansas - Main Office" #1 sponsor was "National Cancer Institute (NCI)" with 24 trials, followed by "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored, "SWOG Cancer Research Network" with 4 trials sponsored and "ETOP IBCSG Partners Foundation" with 4 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Center of Kansas - Main Office" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Center of Kansas - Main Office" are "Adenocarcinoma of the Gastroesophageal Junction" (2 trials), "Breast Cancer" (2 trials), "Cervical Adenocarcinoma" (2 trials), "Cervical Squamous Cell Carcinoma" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Cancer Center of Kansas - Main Office" in a lesser frequency.

Most popular intervention types in "Cancer Center of Kansas - Main Office" are "Drug" (40 trials), "Other" (20 trials), "Biological" (16 trials), "Radiation" (6 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (12 trials), "Paclitaxel" (9 trials), "Bevacizumab" (6 trials), "Carboplatin" (6 trials) and "leucovorin calcium" (6 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Center of Kansas - Main Office" are 31 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Center of Kansas - Main Office". undefined are not yet recruiting, undefined are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Cancer Center of Kansas - Main Office, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Center of Kansas - Main Office, 2 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".